Qualcomm Prevails Against Arm Holdings in Court Again

Arm Holdings (ARM) expressed satisfaction with a jury ruling that upheld its licensing agreements against Qualcomm, awarding minimal damages. The company's GF Value™ suggests it is modestly overvalued by 29.4%, with a GF Score™ of 70. Insider activity shows no recent buying, while gurus hold balanced positions. Arm's P/E ratio is 260.86x, above its 5-year median.

A Delaware jury ruled in a lawsuit between Qualcomm (QCOM) and Arm Holdings (ARM), finding ARM breached its license agreement with QCOM but also ruling in ARM's favor on four claims. QCOM's stock rose nearly 2%, while ARM's fell 0.3%. The case involved disputes over software tools, pricing, and commercial negotiations. ARM's stock has gained 135% YTD, while QCOM's has risen about 2%.

Qualcomm won a jury ruling against Arm, claiming Arm violated their licensing agreement. Arm's stock fell 1% post-verdict. Arm is valued at $255.06, 29.8% above GF Value™ of $196.51, with a GF Score™ of 70/100. Analysts note high P/E ratio and insider selling as cautionary signs for investors.

A US jury awarded Qualcomm $2 in nominal damages in a dispute with Arm Holdings over a licensing agreement, finding Arm breached the contract and interfered with Qualcomm's business. Arm has not commented. Arm's shares fell over 1% after the news.

Qualcomm (QCOM) won a lawsuit against Arm, alleging breach of licensing agreement. Shares rose 2.5%, while Arm's fell 2.2%. Qualcomm offers a 1.92% dividend yield, 41% payout ratio, and 6.8% 3-year dividend growth. Its GF Score is 92/100, indicating strong financial health. Insider activity shows $22.2M in sales, mixed institutional interest.

Arm reported a favorable jury verdict in its litigation with Qualcomm, with the jury finding for Arm on four claims and awarding only $1 in damages on Qualcomm's other two claims. Arm stated it operated in good faith under its technology license agreement and remains focused on delivering technology and creating value for shareholders.